Yeah,they always talked about completing enrollment in the second quarter and the trials then would be finished six months later.Today he was talking about finishing the trials around the end of the year ,give or take a few months.I hadn't heard that before.I think that's telling but that might be paranoia brought on by past experiences with MNKD.

Hakan S. Edstrom

"Well, as I mentioned, I mean, we have, I think, 42 sites already enrolled and enrolling patients in the Type 1 and, if I remember correctly, 35 in the Type 2. So certainly, those are expanding by the day. So right now, basically, what I can confidently say, that we will -- we do expect certainly to complete the enrollment within the second quarter. That will allow us to complete the trials by, around the end of the year, allowing for a submission in the first half of 2013. So there are no indications at this point that we need to change those anticipated schedules."

http://seekingalpha.com/article/385161-mannkind-s-ceo-discusses-q4-2011-results-earnings-call-transcript?all=false&find=trials